Condition
Clinical Stage III Cutaneous Melanoma AJCC v8 clinical trials and research
Research outlook What's coming for Melanoma: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 8 Clinical Stage III Cutaneous Melanoma AJCC v8 clinical trials that are recruiting, in United States. By phase: Phase 2 (3), Phase 1 (2), Phase 1/2 (2). The most active sponsors are Mayo Clinic (3), National Cancer Institute (NCI) (2), M.D. Anderson Cancer Center (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 1Country
Newest Clinical Stage III Cutaneous Melanoma AJCC v8 clinical trials
All recruiting trials (8)
-
Sulforaphane to help prevent new melanomas in people with many atypical moles and a history of melanoma
This phase 2 trial tests whether taking sulforaphane daily can help prevent new melanomas in people with multiple atypical nevi and a prior melanoma history.
-
Comparing home and clinic administration of nivolumab for cancer treatment
This study tests whether giving cancer patients their treatment at home instead of in a clinic makes them feel better and prefer their care more.
-
Monitoring T Cell Responses in Cancer Patients Receiving Anti-PD-1 Therapy
This study is trying to see how T cells in the blood can help doctors understand how well anti-PD-1 therapy works for people with melanoma, lung cancer, and other cancers.
-
Combining immunotherapy with prednisone and sirolimus for kidney transplant recipients with advanced skin cancer
This study is testing a new treatment that combines two immunotherapy drugs with prednisone and sirolimus to see if it helps kidney transplant recipients with advanced skin cancer while keeping their transplanted kidney safe.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
-
Combining cabozantinib and nivolumab to treat advanced melanoma and head and neck cancer
This study is testing a combination of two cancer drugs, cabozantinib and nivolumab, to see if they can help people with advanced melanoma or head and neck cancer while also looking at how to better match treatments to patients based on their tumor characteristics.
-
Treatment of advanced solid tumors with IACS-6274 and other medications
This study is testing a new drug called IACS-6274, alone and with other medications, to see how well it can help people with advanced solid tumors and what the safest dose is.
-
Exploring gut microbiome and fecal transplant effects on GI issues in cancer patients
This study is testing how the gut bacteria affect stomach issues in cancer patients receiving certain treatments and whether a stool transplant can help relieve those problems.
Related topics
Quick answers
How many Clinical Stage III Cutaneous Melanoma AJCC v8 clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1: 2, Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.